ICRA Confirms Cyient DLM IPO Fund Use

ICRA Limited, the monitoring agency, has filed its final report on Cyient DLM's IPO fund utilization up to March 31, 2026. The report confirms that the company used its IPO proceeds in line with its offer document. A special resolution passed in March 2026 allowed funds to be reallocated primarily for working capital needs. The total net proceeds were revised down to ₹663.15 Crore, mainly due to lower issue expenses totaling ₹4.19 Crore.

Investor Confidence Boosted

This independent validation by ICRA boosts investor confidence in Cyient DLM's financial stewardship and its adherence to disclosure rules. The company's flexibility in reallocating capital to meet evolving business requirements, such as strengthening working capital, demonstrates its ability to manage funds effectively.

Original IPO Fund Allocation

Cyient DLM, an electronic manufacturing services (EMS) provider, raised about ₹592 Crore in its June-July 2023 IPO. These funds were originally intended for capital expenditure, including setting up a new manufacturing facility, debt repayment, and working capital.

Key Takeaways

The company's validated use of funds allows it to focus on operational expansion and business growth. This confirmation provides assurance regarding its capital allocation strategy.

Competitive Landscape

Cyient DLM operates in the competitive Indian EMS sector alongside peers like Dixon Technologies, Amber Enterprises India Ltd, and Kaynes Technology India Ltd. These companies are key players in electronics manufacturing for various sectors and often seek funding for expansion and operational efficiency.

Key Financial Figures

The IPO's revised net proceeds were ₹663.15 Crore. By the end of the fourth quarter of fiscal year 2026, ₹618.03 Crore had been utilized, leaving an unutilized balance of ₹45.13 Crore.

What Investors Will Watch

Investors will monitor future ICRA reports on IPO fund use, along with Cyient DLM's financial performance and operational execution. The company's plans for the remaining IPO funds and its future capital expenditure strategies will also be key areas of interest.